These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20696831)

  • 1. Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach.
    Raghavan S; Ostberg AK; Flach CF; Ekman A; Blomquist M; Czerkinsky C; Holmgren J
    Infect Immun; 2010 Oct; 78(10):4251-60. PubMed ID: 20696831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.
    Sjökvist Ottsjö L; Jeverstam F; Yrlid L; Wenzel AU; Walduck AK; Raghavan S
    Immunology; 2017 Feb; 150(2):172-183. PubMed ID: 27676456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice.
    Flach CF; Mozer M; Sundquist M; Holmgren J; Raghavan S
    Vaccine; 2012 Feb; 30(9):1636-43. PubMed ID: 22230589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
    Nyström J; Raghavan S; Svennerholm AM
    Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of circulating integrin α4β7
    Akter S; Jeverstam F; Lundgren A; Magnusson MK; Walduck A; Qadri F; Bhuiyan TR; Raghavan S
    Helicobacter; 2019 Dec; 24(6):e12658. PubMed ID: 31502365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
    Sjökvist Ottsjö L; Flach CF; Clements J; Holmgren J; Raghavan S
    Infect Immun; 2013 May; 81(5):1532-40. PubMed ID: 23439305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the Roles of IFN-γ and IL-17A in Inflammation and Protection against Helicobacter pylori Infection.
    Sjökvist Ottsjö L; Flach CF; Nilsson S; Malefyt Rde W; Walduck AK; Raghavan S
    PLoS One; 2015; 10(7):e0131444. PubMed ID: 26168305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase.
    Flach CF; Östberg AK; Nilsson AT; Malefyt Rde W; Raghavan S
    Infect Immun; 2011 Feb; 79(2):879-86. PubMed ID: 21078851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
    Akhiani AA; Stensson A; Schön K; Lycke N
    Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.
    Ermak TH; Giannasca PJ; Nichols R; Myers GA; Nedrud J; Weltzin R; Lee CK; Kleanthous H; Monath TP
    J Exp Med; 1998 Dec; 188(12):2277-88. PubMed ID: 9858514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection.
    Kleanthous H; Myers GA; Georgakopoulos KM; Tibbitts TJ; Ingrassia JW; Gray HL; Ding R; Zhang ZZ; Lei W; Nichols R; Lee CK; Ermak TH; Monath TP
    Infect Immun; 1998 Jun; 66(6):2879-86. PubMed ID: 9596763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral immunization of BALB/c mice with recombinant Helicobacter pylori antigens and double mutant heat-labile toxin (dmLT) induces prophylactic protective immunity against H. pylori infection.
    Zhong Y; Chen J; Liu Y; Zhang Y; Tang C; Wang X; Wang P; Chen W; Wei B; Liu M
    Microb Pathog; 2020 Aug; 145():104229. PubMed ID: 32353579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
    Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S
    Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes.
    Li Y; Chen Z; Ye J; Ning L; Luo J; Zhang L; Jiang Y; Xi Y; Ning Y
    Helicobacter; 2016 Jun; 21(3):234-48. PubMed ID: 26332255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection.
    Lü L; Zeng HQ; Wang PL; Shen W; Xiang TX; Mei ZC
    Clin Vaccine Immunol; 2011 Nov; 18(11):1957-61. PubMed ID: 21900527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
    Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
    Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection.
    Hickey DK; Aldwell FE; Tan ZY; Bao S; Beagley KW
    Vaccine; 2009 Nov; 27(50):6983-90. PubMed ID: 19800441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homing commitment of lymphocytes activated in the human gastric and intestinal mucosa.
    Quiding-Järbrink M; Ahlstedt I; Lindholm C; Johansson EL; Lönroth H
    Gut; 2001 Oct; 49(4):519-25. PubMed ID: 11559649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.